Article
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
The New England journal of medicine - 1 Oct 2015
Morillo Carlos A, Marin-Neto Jose Antonio, Avezum Alvaro, Sosa-Estani Sergio, Rassi Anis, Rosas Fernando, Villena Erick, Quiroz Roberto, Bonilla Rina, Britto Constança, Guhl Felipe, Velazquez Elsa, Bonilla Laura, Meeks Brandi, Rao-Melacini Purnima, Pogue Janice, Mattos Antonio, Lazdins Janis, Rassi Anis, Connolly Stuart J, Yusuf Salim
Abstract excerpt
BACKGROUND: The role of trypanocidal therapy in patients with established Chagas' cardiomyopathy is unproven. METHODS: We conducted a prospective, multicenter, randomized study involving 2854 patients with Chagas' cardiomyopathy who received benznidazole or placebo for up to 80 days and were followed for a mean of 5.4 years. The primary outcome in the time-to-event analysis was the first event of any of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
